Table 3.
Groupa | N | Baseline | Follow-up | ||||
---|---|---|---|---|---|---|---|
Age | Steps/day | Age | Steps/day | ||||
M | M | 95% CI | M | M | 95% CI | ||
LL | 12 | 66.0 | 7189 | (6146, 8231) | 73.0 | 6258 | (5068, 7447) |
HL | 9 | 64.7 | 11,182 | (9094, 13,269) | 71.7 | 7441* | (5797, 9084) |
LH | 10 | 60.8 | 8005 | (7463, 8546) | 67.8 | 13247* | (10,538, 15,957) |
HH | 28 | 61.7 | 13,527 | (12,434, 14,621) | 68.7 | 14747* | (13,319, 16,175) |
M Mean, 95% CI Confidence interval
* – statistically significant at p < 0.05
a LL Low-low group (women not meeting step-based guidelines nor in baseline neither in follow-up), HL High-low group (women meeting step-based guidelines at baseline but not in follow-up), LH Low-high group (women meeting step-based guidelines at follow-up but not in baseline), HH High-high group (women meeting step-based guidelines at both time points)